Now Live: The World’s Most Powerful AI Factory for Pharmaceutical Discovery and Development
Eli Lilly launches LillyPod, the industry's first internally owned NVIDIA DGX SuperPOD for accelerated drug discovery.
Lilly this week launched the most powerful AI factory wholly owned and operated by a pharmaceutical company to help its teams make meaningful medical advancements faster, more accurately and at unprecedented scale. Dubbed LillyPod, it’s the world’s first NVIDIA DGX SuperPOD with ...
NVIDIA Blog
Source

Generated insight by OnAirToday AI
LillyPod marks a pivotal shift toward vertical integration in drug discovery, allowing pharmaceutical giants to bypass third-party bottlenecks. By leveraging dedicated supercomputing infrastructure, the company can compress R&D timelines and optimize molecular screening with unprecedented internal control.

Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.